Literature DB >> 15553950

Surgical decompression for cervical spondylotic myelopathy: correlation between operative outcomes and MRI of the spinal cord.

Charalambos A Papadopoulos1, Pavlos Katonis, Panayiotis J Papagelopoulos, Spyridon Karampekios, Alexander G Hadjipavlou.   

Abstract

Forty-two patients who underwent decompressive surgery for cervical spondylotic myelopathy were studied. The pre- and postoperative magnetic resonance imaging (MRI) findings and the Japanese Orthopedic Association score were analyzed to evaluate whether the different appearances of intramedullary high-signal intensity on T2-weighted MRI are related to the surgical prognosis. Magnetic resonance imaging signal intensities were classified as type 0 if no intramedullary high-signal intensity on T2-weighted images was noted, type 1 if high-signal intensity involved only one segment, and type 2 if high-signal intensity extended over two segments. Statistical analyses of the recovery ratio showed that type 0 and type 1 intramedullary high-signal intensity indicates better prognosis than type 2.

Entities:  

Mesh:

Year:  2004        PMID: 15553950     DOI: 10.3928/0147-7447-20041001-19

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  11 in total

Review 1.  Myelopathy.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-05       Impact factor: 3.825

2.  Quantitative magnetic resonance imaging analysis correlates with surgical outcome of cervical spondylotic myelopathy.

Authors:  L-Q Sun; Y-M Li; X Wang; H-C Cao
Journal:  Spinal Cord       Date:  2014-11-18       Impact factor: 2.772

Review 3.  A summary of assessment tools for patients suffering from cervical spondylotic myelopathy: a systematic review on validity, reliability and responsiveness.

Authors:  Anoushka Singh; Lindsay Tetreault; Adrian Casey; Rodney Laing; Patrick Statham; Michael G Fehlings
Journal:  Eur Spine J       Date:  2013-09-05       Impact factor: 3.134

4.  The relevance of intramedullary high signal intensity and gadolinium (Gd-DTPA) enhancement to the clinical outcome in cervical compressive myelopathy.

Authors:  Yong Eun Cho; Jun Jae Shin; Keun Su Kim; Dong Kyu Chin; Sung Uk Kuh; Ji Hae Lee; Woo Ho Cho
Journal:  Eur Spine J       Date:  2011-07-22       Impact factor: 3.134

Review 5.  Does the type of T2-weighted hyperintensity influence surgical outcome in patients with cervical spondylotic myelopathy? A review.

Authors:  Aditya Vedantam; Vedantam Rajshekhar
Journal:  Eur Spine J       Date:  2012-08-25       Impact factor: 3.134

Review 6.  Degenerative cervical myelopathy - update and future directions.

Authors:  Jetan H Badhiwala; Christopher S Ahuja; Muhammad A Akbar; Christopher D Witiw; Farshad Nassiri; Julio C Furlan; Armin Curt; Jefferson R Wilson; Michael G Fehlings
Journal:  Nat Rev Neurol       Date:  2020-01-23       Impact factor: 42.937

7.  Length of MRI signal may predict outcome in advanced cervical spondylotic myelopathy.

Authors:  Amro F Al-Habib; Ahmed M AlAqeel; Abdulrahman S Aldakkan; Fahad B AlBadr; Shaffi A Shaik
Journal:  Neurosciences (Riyadh)       Date:  2015-01       Impact factor: 0.906

8.  Clinical Predictors of Surgical Outcomes and Imaging Features in Single Segmental Cervical Spondylotic Myelopathy with Lower Cervical Instability.

Authors:  Kuan Lu; Xianda Gao; Tong Tong; Dechao Miao; Wenyuan Ding; Yong Shen
Journal:  Med Sci Monit       Date:  2017-07-30

9.  Clinical and Imaging Predictors of Surgical Outcome in Multilevel Cervical Ossification of Posterior Longitudinal Ligament: An Analysis of 184 Patients.

Authors:  Yifei Gu; Jueqian Shi; Peng Cao; Wen Yuan; Huiqiao Wu; Lili Yang; Ye Tian; Lei Liang
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

Review 10.  The value of preoperative magnetic resonance imaging in predicting postoperative recovery in patients with cervical spondylosis myelopathy: a meta-analysis.

Authors:  Hui Chen; Jun Pan; Majid Nisar; Huan Bei Zeng; Li Fang Dai; Chao Lou; Si Pin Zhu; Bing Dai; Guang Heng Xiang
Journal:  Clinics (Sao Paulo)       Date:  2016-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.